Management of Early Esophageal Cancer

Advances in Surgery

Volumn 41, Issue , 2007, Pages 229-239

  Theisen, J ^a   Feith, M ^a   Stein, H J ^b   Siewert, J R ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 34548685617     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2007.05.016     Document Type: Review

References (50)

1. Stein H.J., Feith M., and Siewert J.R. Malignant degeneration of Barrett's esophagus: clinical point of view. Recent Results Cancer Res 155 (2000) 42-53
2. Flejou J.F. Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 54 (2005) i6-i12
3. Spechler S.J. Barrett's esophagus. N Engl J Med 346 (2002) 836-842
4. Sharma P., and Sidorenko E.I. Are screening and surveillance for Barrett's oesophagus really worthwhile?. Gut 54 (2005) i27-i32
5. Peters J.H., Clark G.W., Ireland A.P., et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108 (1994) 813-822
6. van Sandick J.W., van Lanschot J.J., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
7. Stein H.J., Feith M., Müller J., et al. Limited resection for early Barrett's cancer. Ann Surg 232 (2000) 733-742
8. Stein H.J., Feith M., von Rahden B.H., et al. Approach to early Barrett's cancer. World J Surg 27 (2003) 1040-1046
9. Buttar N.S., Wang K.K., Lutzke L.S., et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 54 (2001) 828-838
10. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
11. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14 (2002) 1085-1091
12. May A., Gossner L., Pech O., et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 34 (2002) 604-610
13. Ormsby A.H., Petras R.E., Henricks W.H., et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 51 (2002) 671-676
14. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 (2000) 251-255
15. Werner M., Flejou J.F., Hainaut P., et al. Adenocarcinoma of the oesophagus. In: Hamilton S.R., and Aaltonen L. (Eds). World Health Organization classification of tumours: pathology and genetics-tumours of the digestive system (2000), IARC Press, Lyon 20-25
16. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high grade dysplasia. Gastroenterology 120 (2001) 1607-1619
17. Stein H.J. Panel of experts: esophageal cancer: screening and surveillance. Results of a consensus conference. Dis Esophagus 9 (1996) 3-19
18. Reid B.J., Levine D.S., Longton G., et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95 (2000) 1669-1676
19. Collard J.M. High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clin N Am 12 (2002) 77-92
20. Holscher A.H., Bollschweiler E., Schneider P.M., et al. Early adenocarcinoma in Barrett's oesophagus. Br J Surg 84 (1997) 1470-1473
21. Headrick J.R., Nichols F.C., Miller D.L., et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 73 (2002) 1697-1703
22. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: A plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240 (2004) 962-972
23. Altorki N., Kent M., Ferrara C., et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236 (2002) 177-183
24. Kirby J.D. Quality of life after oesophagectomy: the patients' perspective. Dis Esophagus 12 (1999) 168-171
25. Fernando H.C., Luketich J.D., Buenaventura P.O., et al. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg 22 (2002) 1-6
26. Banki F., Mason R., DeMeester S.R., et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 236 (2002) 324-336
27. van Sandick J.W., van Lanschot J.J., ten Kate F.J., et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 88 (2000) 2429-2437
28. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120 (2001) 1630-1639
29. Stein H.J., Feith M., Brücher B.L.D.M., et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242 (2005) 566-573
30. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 230 (1999) 433-438
31. Streitz Jr. J.M., Ellis Jr. F.H., Gibb S.P., et al. Adenocarcinoma in Barrett's esophagus. A Clinicopathologic study of 65 cases. Ann Surg 213 (1991) 122-125
32. Buskens C.J., Westerterp M., Lagarde S.M., et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60 (2004) 703-710
33. Rice T.W., Blackstone E.H., Goldblum J.R., et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 122 (2001) 1077-1090
34. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 117 (1999) 16-23
35. Brücher B.L.D.M., Stein H.J., Werner M., et al. Lymphatic vessel invasion is an independent prognostic factor in patients with primary resected esophageal squamous cell cancer. Cancer 92 (2001) 2228-2233
36. v Rahden B.H.A., Stein H.J., Feith M., et al. Lymphatic vessel invasion as prognostic factor in patients with primary resected adenocarcinoma of the esophagogastric junction. J Clin Oncol 23 (2005) 874-879
37. May A., Gunter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 53 (2004) 634-640
38. Vieth M., Ell C., Gossner L., et al. Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy 36 (2004) 776-781
39. Merendino K.A., and Dillard D.H. The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiological abnormalities at the esophagogastric junction. Ann Surg 142 (1955) 486-506
40. Siewert J.R., and Stein H.J. Lymphadenectomy for esophageal cancer. Langenbecks Arch Surg 384 (1999) 141-148
41. Takeshita K., Saito N., Saeki I., et al. Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: surgical techniques and evaluation of postoperative function. Surgery 121 (1997) 278-286
42. Gaissert H.A., Mathisen D.J., Grillo H.C., et al. Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 106 (1993) 860-866
43. Gerzic Z.B. Modification of the Merendino procedure. Dis Esophagus 10 (1997) 270-275
44. Mansour K.A., Bryan F.C., and Carlson G.W. Bowel interposition for esophageal replacement: twenty-five-year experience. Ann Thorac Surg 64 (1997) 752-756
45. Maish M.S., and DeMeester S.R. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 78 (2004) 1777-1782
46. Ueno H., Hirai T., Nishimoto N., et al. Prediction of lymph node metastasis by p53, p21(Waf1), and PCNA expression in esophageal cancer patients. J Exp Clin Cancer Res 22 (2003) 239-245
47. Kan T., Shimada Y., Sato F., et al. Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol 11 (2004) 1070-1078
48. Burian M., Stein H.J., Sendler A., et al. Sentinel node detection in Barrett's and cardia cancer. Ann Surg Oncol 11 (2004) 255-258
49. Lamb P.J., Griffin S.M., Burt A.D., et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 92 (2005) 60-67
50. Kato H., Miyazaki T., Nakajima M., et al. Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 98 (2003) 932-939